logo
Select company
Select metric
$ 4.26MTotal Liabilities
VS
Market
93
Sector
88
Industry
86
History
78
$ 0.74Close
$ 0.58 - $ 3.8 52-Week Range
Ticker Information

Ticker

GTBP

Company Name

GT BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GT BIOPHARMA INC - Total Liabilities Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GTBP - Liabilities Historical data
DateTotal Liabilities
6/30/2025$ 4.26M
3/31/2025$ 3.64M
12/31/2024$ 5.9M
9/30/2024$ 4.66M
6/30/2024$ 3.76M
3/31/2024$ 4.6M
12/31/2023$ 6.63M
9/30/2023$ 6.14M
6/30/2023$ 6.38M
3/31/2023$ 7.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GT BIOPHARMA INC's latest trailing twelve months (TTM) Liabilities stands at $ 30.69M.
  • Over the past 5 years, GT BIOPHARMA INC's average Liabilities has been $ 8.42M.
  • The median Liabilities for GT BIOPHARMA INC during this period was $ 5.51M
  • GT BIOPHARMA INC reached its highest Liabilities over the past 5 years at $ 35.09M.
  • The lowest Liabilities recorded by GT BIOPHARMA INC in the same timeframe $ 3.28M

Definition of Total Liabilities

[Balance Sheet] Total liabilities are the sum of all possible claims against the company. Common examples are [Debt], [Payables], deferred revenues, issued bonds, warranties, and tax liabilities.

GTBP - Total Liabilities, Last 5 years

$ 3.28M

Minimum

Jun 30, 2021

$ 35.09M

Maximum

Dec 31, 2020

$ 8.42M

Average

$ 5.51M

Median

Liabilities Benchmark Analysis

The chart above depicts the distribution of Liabilities for companies in the Total Stock Market. The average Liabilities of the companies is $ 615.97M with a standard deviation of $ 857.74M.
The following table provides additional summary stats:
Liabilities in the Market:
filtered constituents3.32K
min$ 0
max$ 3.5B
average$ 615.97M
median$ 180.93M
std$ 857.74M